Skip to main content
OpenTrials
Completed

NCT Number: NCT01090297

Continuous Positive Airway Pressure (CPAP) Mode Impact on Clinical Blood Arterial Pressure

Background: Continuous positive airway pressure (CPAP) is the first line therapy for obstructive sleep apnea syndrome (OSAS). Two positive airway pressure (PAP) modalities can be used: Fixed pressure, in which the effective pressure is set and kept constant all night, and auto CPAP devices where the positive pressure changes during the night depend on patient's requirements.

Hypothesis: Pressure variations associated with autoCPAP functioning can lead to sleep fragmentation and alterations in sleep structure. This can limit blood pressure dipping during sleep and then impact clinical blood pressure reduction.

Main objective: To compare in a randomized controlled trial 4 months clinical blood pressure (BP) evolution depending on CPAP mode: fixed pressure versus autoCPAP. Secondary outcomes: Evolution of arterial stiffness, biological parameters, quality of life and symptoms.

Methods: Patients will be randomised depending on CPAP mode. Baseline and 4 months evaluation will include: 24-h ambulatory blood pressure monitoring, clinical BP measurements and carotid-to-femoral pulse wave velocity (PWV). Patients will also complete quality of life and symptoms questionnaires.

2 interim analysis will be carried out when 150 and 220 patients respectively will have completed the study. The Peto's method will be used to correct the p-values.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

AGIR à Dom

Meylan, 38240, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age between 18 and 80 years
  • patients who gave written informed consent
  • patients who subscribed a social insurance
  • SAOS patients who need CPAP treatment.

Exclusion criteria

  • cardiac failure known and treated
  • central Apnea syndrome
  • patients who stopped CPAP treatment in the previous year
  • pregnant women
  • patients under guardianship
  • imprisoned patients, patients in hospital
  • patients included in an other clinical study

Treatment and study plan

S8 Spirit 2

Device

3 types of Continuous Positive Airway Pressure (CPAP) device: S8 Spirit 2, Somnosmart 2, Remstar Auto.

These 3 types of CPAP can be set in both mode of pressure.

Somnosmart 2

Device

3 types of Continuous Positive Airway Pressure (CPAP) device: S8 Spirit 2, Somnosmart 2, Remstar Auto.

These 3 types of CPAP can be set in both mode of pressure.

Remstar Auto

Device

3 types of Continuous Positive Airway Pressure (CPAP) device: S8 Spirit 2, Somnosmart 2, Remstar Auto.

These 3 types of CPAP can be set in both mode of pressure.

Primary outcomes

  1. Clinical blood pressure

    Time frame: Before treatment, 4 months after treatment

Secondary outcomes

  1. Pulse Wave Velocity

    Time frame: Before treatment, 4 months after treatment

  2. 24 hours Blood Pressure measure

    Time frame: Before treatment, after 4 months of treatment

Sponsors and collaborators

Lead sponsor

AGIR à Dom

Other

Registry information

Official study title

CPAP Treatment : Fixed Versus Auto-adjusting Mode Impact on Clinical Blood Arterial Pressure. Randomised, Controlled and Double Blinded Trial in SAOS Patients

Acronym: AgirSASadom

Important dates

Study start
2009
Primary completion
2012
Study completion
2012
First posted
Mar 19, 2010
Registry last updated
Feb 15, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.